View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Thomas J. Schiessle
  • Thomas J. Schiessle

Entwicklungspipeline macht zügig Fortschritte - Aktie preiswert

Das Prüfprogramm für das Leitprojekt HDP-101 zeigt unverändert Sicherheit und gute Verträglichkeit. Die 4. Dosiseskalations-Gruppe war im Q3/23 recht zügig abgeschlossen worden; nun werden Patienten für die 5. Kohorte (100 g/kg) rekrutiert. Ein Patient, der seit 9 Monaten kein Fortschreiten der Krankheit (stable disease) zeigt, erhielt zwölf Dosen HDP-101 Monotherapie und erhält nun die Möglichkeit der nächsthöheren Dosis (80 µg/kg). Der Übergang in die Phase 2a mit HDP-101 könnte u.E. im H1/24...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 19, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: August 15, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Mirati Therapeutics Inc: 1 director

A director at Mirati Therapeutics Inc sold 2,546 shares at 44.660USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

MIRATI THERAP sees an upgrade to Neutral thanks to a better star ratin...

The independent financial analyst theScreener just awarded an improved star rating to MIRATI THERAP (CA), active in the Biotechnology industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 1 out of 4 possible stars. Given its market behaviour as moderately risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Neutral; the title, however, remains unattractive. As of the analysis date March 4, 2022, ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

WIX WIX.COM LTD.
TWOU 2U INC.
TGTX TG THERAPEUTICS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SGMO SANGAMO THERAPEUTICS INC.
RRC RANGE RESOURCES CORPORATION
RP REALPAGE INC.
RNG RINGCENTRAL INC. CLASS A
RGR STURM RUGER & COMPANY INC.
RGEN REPLIGEN CORPORATION
PSX PHILLIPS 66
PRLB PROTO LABS INC.
NERV MINERVA NEUROSCIENCES
NBIX NEUROCRINE BIOSCIENCES INC.
MRTX MIRATI THERAPEUTICS INC.
MPWR MONOLITHIC POWER SYSTEMS INC.
MKC MCCORMICK & COMPANY INCORPORATED
LOPE GRAND CANYON EDUCATION INC.
JKHY JACK HENRY & ASSOCIATES INC.
IPHI INPHI CORPORATION
IPGP IPG PHOTONICS CORPORATION
IIVI II-VI INCORPORATED
GWPH GW PHARMACEUTICALS PLC SPONSORED ADR
FTNT FORTINET INC.
FAST FASTENAL COMPANY
EXEL EXELIXIS INC.
CYTK CYTOKINETICS INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
BOX BOX INC. CLASS A
BMY BRISTOL-MYERS SQUIBB COMPANY
BGS B&G FOODS INC.
ATRC ATRICURE INC.
ALRM ALARM.COM HOLDINGS INC.
ABMD ABIOMED INC.
SHW SHERWIN-WILLIAMS COMPANY
AEM. AGNICO EAGLE MINES LIMITED
OR OSISKO GOLD ROYALTIES LTD
ENPH ENPHASE ENERGY INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
SAM BOSTON BEER COMPANY INC. CLASS A
CENTA CENTRAL GARDEN & PET CO A
MRAM EVERSPIN TECHNOLOGIES
COUP COUPA SOFTWARE INC.
NTLA INTELLIA THERAPEUTICS INC.
AXON AXON ENTERPRISE INC
NOMDN NOMAD FOODS LTD.
MDGL MADRIGAL PHARMACEUTICALS
OKTA OKTA INC. CLASS A
KALA KALA PHARMACEUTICALS INC.
BAND BANDWIDTH CLASS A
ACMR ACM RESEARCH
AVYA AVAYA HOLDINGS
SPY SPDR S&P 500 ETF
AZN ASTRAZENECA PLC ADS
DBX DROPBOX INC. CLASS A
LASR NLIGHT
LQDA LIQUIDIA CORPORATION
CNST CONSTELLATION PHARMACEUTICALS
ESTC ELASTIC N.V.
ARAV ARAVIVE
NGM NGM BIOPHARMACEUTICALS
NIU NIU TECHNOLOGIES ADS (N SHARES)
PD PAGERDUTY
BYND BEYOND MEAT
SCPL SCIPLAY
AVTR AVANTOR INC.
FSLY FASTLY
BSGM BIOSIG TECHNOLOGIES INC
UI UBIQUITI INC.
PSN PARSONS
NVAX NOVAVAX INC.
CRNC CERENCE
DDOG DATADOG INC CLASS A
LVGO LIVONGO HEALTH
FVRR FIVERR INTERNATIONAL
AQST AQUESTIVE THERAPEUTICS
TWST TWIST BIOSCIENCE
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
REYN REYNOLDS CONSUMER PRODUCTS
SDGR INC.
SCHRÖDINGER
INC.
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: February 6, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: February 1, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: February 1, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: January 31, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: January 25, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: January 14, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch